Emily Wise, MD
Dermatology · Wellesley, MANPI 1487882270
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $83,126 of the $90,292 with a category attached, or 92.1%. Galderma Laboratories, L.p. accounts for 96.8% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2023 at $38,369 and has fallen 84.0% since, to $6,128 in 2025. Among dermatology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 229 payments — averaging $394.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$87K
- AbbVie$885
- LEO Pharma Inc.$430
- Lilly USA, LLC$381
- Regeneron Healthcare Solutions, Inc.$276
- Sun Pharmaceutical Industries Inc.$172
- plus $724 from 12 others
What the payments were for
- Speaking & faculty fees$83,12692%
- Travel & lodging$8211%
- Food & beverage$6,3107%
- Education$360%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 110 | $87,424 |
| AbbVie(2 entities) | 38 | $885 |
| LEO Pharma Inc. | 24 | $430 |
| Lilly USA, LLC | 9 | $381 |
| Regeneron Healthcare Solutions, Inc. | 12 | $276 |
| Sun Pharmaceutical Industries Inc. | 4 | $172 |
| Sanofi | 2 | $120 |
| Solta Medical, A Division Of Bausch Health US, LLC | 4 | $93 |
| Novartis | 5 | $92 |
| Pfizer | 4 | $78 |
| Bristol Myers Squibb | 3 | $69 |
| Incyte Corporation | 3 | $67 |
| Almirall LLC | 4 | $57 |
| VYNE Pharmaceuticals Inc. | 2 | $47 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $39 |
| Aclaris Therapeutics, Inc. | 1 | $24 |
| LNHC, Inc | 1 | $24 |
| UCB, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$90,292 in reported general payments places this provider in the 95th percentile of 552 dermatology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 43 | $2,312 |
| Clobetasol Propionate | 12 | $1,057 |
| Metronidazole | 12 | $448 |
| Triamcinolone Acetonide | 42 | $384 |
| Minoxidil | 25 | $319 |
| Doxycycline Hyclate | 12 | $314 |
| Ketoconazole | 24 | $306 |
| Betamethasone Dipropionate | 11 | $245 |
| Finasteride | 11 | $150 |
| Mupirocin | 14 | $142 |
| Hydrocortisone | 25 | $96 |
| Nystatin | 11 | $87 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Wellesley
- Ruth TedaldiWellesley$145K
- John HarrisWorcester$15M
- Ethan LernerCharlestown$1.7M
- Michael KaminerChestnut Hill$1.1M
- Jeffrey SobellChestnut Hill$986K
- Erik DominguesFall River$736K
- Alexandra KimballBoston$680K
- Arash MostaghimiBoston$591K
- David GreensteinBeverly$540K
- Brian HiblerBoston$498K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.